Oncology Today with Dr Neil Love

Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies

Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

Oncology Nursing Update: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates

Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses

5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses

Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management

Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater

Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies

Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series

Optimizing the Management of Tenosynovial Giant Cell Tumor

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

Practical Perspectives: Current Management of Chronic Myeloid Leukemia

The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Peripheral T-Cell Lymphoma

The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Optimizing the Management of Dedifferentiated Liposarcoma

Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Management of Metastatic Urothelial Bladder Cancer

Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer

Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Novel Agents and Strategies in Lung Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Optimizing the Identification of HER2-Low Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review

Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer

Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer

Key Presentations on Lymphoma from Recent Major Conferences

Bispecific Antibodies in the Management of Multiple Myeloma

Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

Virtual Case Library: Metastatic Urothelial Bladder Cancer

Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Implications of Recent Data Sets for the Current and Future Management of Breast Cancer

Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer

Blastic Plasmacytoid Dendritic Cell Neoplasm

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

Novel Agents and Strategies in the Treatment of Ovarian Cancer

What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

Optimizing the Management of Metastatic Pancreatic Cancer

The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Meet The Professor: Optimizing the Management of Melanoma

Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series

Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences

Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management

Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia

Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue

Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank

Optimizing the Management of Metastatic Urothelial Bladder Cancer

Special Edition — Current and Future Management of Breast Cancer

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers

Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes

Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari

Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro

Special Edition — Management of Hepatobiliary Cancers

Special Edition — Management of Urothelial Bladder Cancer

Special Edition — Current and Future Management of Breast Cancer

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer

The Implications of New Research Findings for the Management of Endometrial Cancer

Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series

Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition

Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition

Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning

Management of Desmoid Tumors with Dr Mrinal Gounder

Management of HER2-Altered Non-Small Cell Lung Cancer

Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation

Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek

Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles

Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone

Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan

HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano

Management of Gastroesophageal Cancers with Dr Manish Shah

Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa

Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog

Novel Immunotherapeutic Strategies in Melanoma with Dr Omid Hamid

Thyroid Cancer with Dr Eric Sherman

Amyloid Light Chain (AL) Amyloidosis with Dr Jeffrey Zonder

Novel Agents and Strategies in Myelofibrosis with Dr Ruben Mesa

Management of Renal Cell Carcinoma with Dr Toni Choueiri

Management of Hepatocellular Carcinoma with Prof Arndt Vogel

Novel Agents and Strategies in AML with Dr Eytan Stein

Higher-Risk Myelodysplastic Syndromes with Dr Amy DeZern

Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences — With Dr Rachna Shroff

Management of MET-Altered Non-Small Cell Lung Cancer with Dr Rebecca Heist

Current Management of Myelofibrosis with Dr Brady Stein

Neuroendocrine Tumors with Dr Pamela Kunz

BRAF-Mutant Metastatic Melanoma with Prof Axel Hauschild

Management of RET Fusion-Positive Non-Small Cell Lung Cancer with Dr Justin Gainor

Management of Nonmetastatic Urothelial Bladder Cancer with Prof Sia Daneshmand

Management of Small Cell Lung Cancer with Dr Benjamin Levy

BCMA-Directed Therapies for Multiple Myeloma with Dr Amrita Krishnan

Management of Localized Non-Small Cell Lung Cancer with Dr Heather Wakelee

Current and Future Management of Hodgkin Lymphoma with Dr Stephen Ansell

Interstitial Lung Disease in Patients Receiving Anticancer Therapy with Dr Charles Powell

Endometrial Cancer Edition with Dr Mansoor Raza Mirza

Ocular Toxicities in Patients Receiving Anticancer Therapy with Dr Asim Farooq

Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting with Dr Joshua Sabari

KRAS-Mutant Non-Small Cell Lung Cancer

Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting with Dr Brian Slomovitz

Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting with Dr Ezra Cohen

Recent Updates in the Management of HER2-Low Breast Cancer with Dr Shanu Modi

Management of Unresectable Stage III Non-Small Cell Lung Cancer with Drs Jeffrey Bradley and David Spigel

Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting with Dr Sandy Srinivas

Management of Cholangiocarcinoma and Other Biliary Tract Cancers with Professor Juan Valle

Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting with Dr Angela DeMichele

Recent Updates in HER2-Low Breast Cancer with Dr Adam Brufsky

Current and Future Management of Follicular Lymphoma with Dr Loretta Nastoupil

Updates on Ovarian Cancer from SGO 2022 with Dr David O’Malley

PARP Inhibitors in Breast Cancer with Dr Judy Garber

Advances in Soft Tissue Sarcomas with Dr Mark Agulnik

Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari

Key Presentations on Advances in Myeloproliferative Neoplasms from ASH 2021 with Dr Prithviraj Bose

Advances in the Treatment of Hodgkin and Non-Hodgkin Lymphomas from ASH 2021 with Dr Matthew Lunning

Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from ASH 2021

Current Issues in the Research and Management of Localized Hormone Receptor-Positive Breast Cancer with Dr Sara Tolaney.

Recent Advances in the Treatment of Chronic Lymphocytic Leukemia with Dr Peter Hillmen

Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids

Managing Transplant-Ineligible Newly Diagnosed Multiple Myeloma with Dr Saad Zafar Usmani

Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer with Dr Evan Yu

Biomarker-Directed Therapy for Colorectal Cancer with Dr Christopher Lieu

PARP Inhibition in Pancreatic Cancer with Dr Michael Pishvaian

Modern Management of Metastatic Castration-Resistant Prostate Cancer with Dr Alan Bryce

Advances in Genetic Profiling and Targeted Therapies for Colorectal Cancer with Dr Arvind Dasari

Ovarian Cancer with Dr Bradley Monk

NSCLC with EGFR Exon 20 Insertion Mutations with Dr Gregory Riely

Novel Immunotherapeutic Strategies in Melanoma with Dr Adil Daud

Optimal Management of Hodgkin Lymphoma in Younger and Older Patients with Dr Neil Love

Advances in Endometrial Cancer with Dr Matthew Powell

Chronic Lymphocytic Leukemia with Professor Dr Arnon Kater

Myelodysplastic Syndromes with Dr Michael Savona

CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen

Head and Neck Cancer with Dr Cristina Rodriguez

Myeloproliferative Neoplasms with Dr Ruben Mesa

Chronic Myeloid Leukemia with Dr Michael Mauro

Renal Cell Carcinoma with Dr Sumanta Pal

Thyroid Cancer with Dr Marcia Brose

Gastroesophageal Cancers with Dr Samuel Klempner

Management of HER2-Low Breast Cancer with Dr Ian Krop

Key Presentations on Gynecologic Cancers from the 2021 ASCO Annual Meeting with Dr Kathleen Moore

Thyroid Cancer with Dr Lori Wirth

Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal

CAR T-Cell Therapy in Multiple Myeloma with Dr Jesús Berdeja

Key Presentations on Gastrointestinal Cancers from the 2021 ASCO Annual Meeting with Dr Kristen Ciombor

Key Presentations on Breast Cancer from the 2021 ASCO Annual Meeting with Dr Sara Tolaney

Gastroesophageal Cancers with Dr Jaffer Ajani

Key Presentations on Genitourinary Cancers from the 2021 ASCO Annual Meeting with Dr Arjun Balar

Progress in Myelodysplastic Syndromes with Dr Guillermo Garcia-Manero

HER2-Positive Localized Breast Cancer with Dr Adam Brufsky

Genomic Assays in Early Breast Cancer

Advances in the Management of Amyloid Light Chain Amyloidosis with Dr Morie Gertz

Advances in the Management of Cholangiocarcinoma with Dr Mitesh Borad

Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst

Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn

Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander

Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli

Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba

Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia

Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles

Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei

PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín

Predictors of Response to Cancer Immunotherapy with Prof Solange Peters

Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael

Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska

Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram

Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson

New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor

ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton

Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce

Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore

Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre

Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds

Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky

Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer

The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin

Key Presentations on the Treatment of Multiple Myeloma from the 2020 ASH Annual Meeting with Dr Sagar Lonial

Current Challenges of COVID-19 in Southern California with Dr David Quinn

Current Management of and Future Directions in Mesothelioma with Dr Marjorie Zauderer

The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer with Dr Stephen Liu

The Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Ursula Matulonis

The Role of PARP Inhibition in the Management of Breast Cancer with Dr Hope Rugo

The Role of PARP Inhibition in the Management of Prostate Cancer with Dr Maha Hussain

The Role of PARP Inhibition in the Management of Pancreatic Cancer with Dr Philip A Philip

Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt

Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers with Dr David O'Malley

Management of Pancreatic Cancer with Dr Andrew Ko

Key Recent Data Sets in Gastrointestinal Cancers with Dr Philip A Philip

Immune Checkpoint Inhibition in Breast Cancer with Dr Sylvia Adams

The Role of Liquid Biopsy for Cancer Screening with Dr Eric Klein

Novel Agents Under Investigation in Multiple Myeloma with Dr Peter Voorhees

Adjuvant Therapy for ER-Positive Breast Cancer with Prof Stephen Johnston

Management of Non-Small Cell Lung Cancer with ALK and ROS1 Rearrangements with Dr Ross Camidge

Management of Gastroesophageal Cancers with Dr Daniel Catenacci

Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat

Renal Cell Carcinoma

Acute Myeloid Leukemia with FLT3 Mutations

Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

PARP Inhibition in the Management of Pancreatic Cancer

Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy

Front-Line Treatment of Chronic Lymphocytic Leukemia